Exlites Holdings International, Inc. (EXHI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Exlites Holdings International, Inc. (EXHI) trades at $0.40. Exlites Holdings International, Inc. operates in consumer health and wellness and durable medical supply, manufacturing products like heated steering wheels and medical devices. Market cap: $17.62M, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for EXHI: EXHI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates EXHI against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
EXHI: 1/1 perspectives are bearish.
How is this calculated? →Exlites Holdings International, Inc. (EXHI) Healthcare & Pipeline Overview
Exlites Holdings International, Inc. is a Salt Lake City-based company operating since 1979, specializing in consumer health and wellness products and durable medical supply manufacturing. It offers diverse goods from heated steering wheels to medical devices, employing a multi-channel distribution strategy to serve both individual consumers and healthcare institutions through direct sales, retail, and distributor partnerships.
What Is the Investment Thesis for EXHI?
Exlites Holdings International, Inc. operates within the dual markets of consumer health and wellness and durable medical supply, leveraging a diversified product portfolio and contract manufacturing services. With a market capitalization of $17.62M, the company presents a profile typical of smaller, publicly traded entities. A key value driver could stem from the potential for growth within its niche product categories, such as innovative therapy packs and specialized insoles, which address specific consumer needs for comfort and health. The contract manufacturing segment for medical supplies also offers a stable revenue stream, catering to essential healthcare infrastructure like hospitals and nursing homes. However, the company's reported profit margin of -61.3% indicates significant operational challenges and a lack of profitability, which is a critical risk factor. The negative Beta of -0.50 suggests a low correlation with broader market movements, which could be interpreted as either a defensive characteristic or an indicator of limited market engagement for a micro-cap stock. Trading on the OTC Other tier, EXHI faces inherent risks related to limited regulation, disclosure, and potential illiquidity, making due diligence paramount. Future growth catalysts would likely involve successful product development, expansion of its contract manufacturing client base, or improved operational efficiency leading to profitability. Investors would need to monitor the company's ability to achieve sustainable operations and enhance its financial performance.
Based on FMP financials and quantitative analysis
EXHI Key Highlights
- Market Capitalization: $0.02 billion, indicating a micro-cap company operating in specialized markets.
- Profit Margin: -61.3%, reflecting significant unprofitability and operational challenges.
- Beta: -0.50, suggesting a low or inverse correlation with overall market movements, which can be atypical for a small-cap.
- Dividend Yield: None, as the company does not currently distribute dividends to shareholders.
- Operational Longevity: Founded in 1979 and headquartered in Salt Lake City, Utah, demonstrating a long history in its operating sectors.
Who Are EXHI's Competitors?
EXHI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CWB State Street SPDR Bloomberg Convertible Securities ETF | $105.34 | +0.92% | $4.62B | 47 |
| TDV ProShares - S&P Technology Dividend Aristocrats ETF | $100.89 | +1.33% | $293.21M | 47 |
| DAUG FT Vest U.S. Equity Deep Buffer ETF - August | $46.97 | +0.26% | $363.40M | 47 |
| KSTR KraneShares SSE STAR Market 50 Index ETF | $28.75 | +2.00% | $67.07M | 47 |
| FTQGX Fidelity Focused Stock Fund | $48.04 | -2.26% | $5.41B | 44 |
| SHAPX ClearBridge Appreciation A | $36.64 | +0.80% | $9.79B | 44 |
| FGFRX Federated Hermes International Leaders Fund Class R | $47.03 | +1.34% | $1.53B | 44 |
| SBYEX BNY Mellon Diversified Emerging Markets Fund | $23.10 | -0.04% | $48.80M | 44 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are EXHI's Key Strengths?
- Diversified product portfolio across consumer health and medical supplies.
- Established contract manufacturing capabilities for medical devices.
- Multi-channel distribution strategy reaching diverse customer segments.
- Long operational history since 1979, indicating market experience.
What Are EXHI's Weaknesses?
- Significant unprofitability with a -61.3% profit margin.
- Small market capitalization ($0.02B) suggesting limited resources and scale.
- Limited public disclosure as an OTC Other tier company.
- Negative Beta of -0.50, potentially indicating idiosyncratic risk or low market correlation.
What Could Drive EXHI Stock Higher?
- **Upcoming: Enhanced Disclosure**: Any future move by Exlites Holdings International, Inc. to improve its public disclosure status or provide regular financial reports could significantly increase investor confidence and transparency.
- **Ongoing: Expansion of Contract Manufacturing**: Continued growth in securing new contracts or expanding existing relationships for medical supply and device manufacturing could drive revenue and operational stability.
- **Ongoing: New Product Introductions**: The successful launch of innovative consumer health and wellness products or advanced medical supplies could capture new market segments and boost sales.
- **Upcoming: Strategic Partnerships**: Formation of new distribution agreements with major retailers or healthcare networks could significantly broaden market reach and sales volume.
What Are the Key Risks for EXHI?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- **Ongoing: Sustained Unprofitability**: The reported -61.3% profit margin indicates a significant challenge in achieving profitability, which could impact long-term viability and investor confidence.
- **Ongoing: OTC Market Risks**: Trading on the OTC Other tier exposes investors to high risks including illiquidity, limited disclosure, potential for price manipulation, and lack of regulatory oversight.
- **Potential: Intense Competition**: Operating in both consumer health and medical distribution sectors means facing competition from larger, well-capitalized companies with greater resources for R&D, marketing, and distribution.
- **Potential: Regulatory Compliance**: As a manufacturer of medical supplies and devices, Exlites Holdings International, Inc. is subject to stringent regulatory requirements, and any non-compliance could lead to penalties or operational disruptions.
- **Potential: Product Development and Market Acceptance**: The success of new consumer or medical products is dependent on market acceptance and effective commercialization, which carries inherent risks of failure or underperformance.
What Are the Growth Opportunities for EXHI?
- **Expansion in Consumer Health and Wellness Products**: The global consumer health and wellness market is projected to continue its growth trajectory, driven by increasing health consciousness and demand for convenience. Exlites' portfolio of innovative consumer goods, such as electronic hot and cold therapy packs and spring-loaded shoe insoles, positions it to capitalize on this trend. By introducing new, technologically advanced products that address specific comfort and therapeutic needs, the company could expand its market share. Focusing on direct-to-consumer channels and strategic retail partnerships could enhance brand visibility and sales velocity, potentially tapping into a market valued in the hundreds of billions globally, with continuous innovation cycles.
- **Growth in Contract Manufacturing for Medical Supplies**: The demand for outsourced medical device and supply manufacturing is robust, fueled by healthcare providers seeking cost efficiencies and specialized expertise. Exlites' existing contract manufacturing services for hospitals, nursing homes, and assisted living facilities represent a significant growth avenue. By expanding its client base and diversifying the types of medical devices and supplies it can produce, the company could secure larger, long-term contracts. This segment benefits from stable demand and critical infrastructure needs, offering a more predictable revenue stream within the multi-trillion-dollar global healthcare market, particularly in the medical device manufacturing sub-segment.
- **Leveraging Multi-Channel Distribution**: Exlites currently employs a multi-channel strategy including consumer and medical distributors, catalogs, retail partners, and direct-to-consumer sales. Optimizing and expanding these channels presents a substantial growth opportunity. Enhancing e-commerce capabilities for direct sales, forging new partnerships with major retail chains for consumer products, and securing additional distribution agreements with large medical supply networks could significantly broaden market reach. This strategy allows for targeted marketing and efficient logistics, enabling the company to penetrate new geographic regions and demographic segments more effectively over the next 3-5 years.
- **Product Innovation and Diversification**: Continuous innovation in both its consumer and medical product lines is a critical growth driver. For consumer health, developing next-generation battery-operated heated products or advanced ergonomic solutions could capture new market niches. In the medical sector, investing in R&D to offer more sophisticated or specialized medical devices for contract manufacturing could attract higher-value clients. This diversification could include exploring adjacent therapeutic areas or developing products that integrate smart technology, positioning Exlites at the forefront of evolving market demands. Such innovation could unlock new revenue streams within the next 2-4 years.
- **Market Penetration in Specific Healthcare Segments**: While Exlites serves hospitals, nursing homes, and assisted living facilities, there is potential for deeper penetration within these and other specialized healthcare segments. This could involve tailoring product offerings or manufacturing services to specific needs of rehabilitation centers, home healthcare agencies, or specialized clinics. Developing targeted sales and marketing strategies for these segments, highlighting the quality and reliability of Exlites' medical supplies and devices, could lead to increased order volumes and client retention. This focused approach could yield significant growth within existing markets over the medium term (3-5 years).
What Opportunities Does EXHI Have?
- Growing demand in both consumer health/wellness and durable medical supply markets.
- Potential to expand contract manufacturing client base and product types.
- Optimization and expansion of existing multi-channel distribution networks.
- Introduction of new, innovative products in both consumer and medical segments.
What Threats Does EXHI Face?
- Intense competition from larger, more established players in both sectors.
- Regulatory changes in the medical device and supply industry.
- Economic downturns impacting consumer discretionary spending on health and wellness products.
- Risks associated with trading on the OTC Other tier, including illiquidity and limited investor confidence.
What Are EXHI's Competitive Advantages?
- **Product Diversification**: A broad product portfolio spanning both consumer health and medical supplies reduces reliance on a single market segment.
- **Contract Manufacturing Capability**: Expertise in manufacturing medical devices and supplies provides a specialized service offering to the healthcare industry.
- **Established Distribution Network**: Utilization of multiple channels, including direct sales, distributors, and retail partners, enhances market access and reach.
- **Longevity and Experience**: Founded in 1979, the company possesses decades of operational experience in its target markets, suggesting established processes and relationships.
What Does EXHI Do?
Exlites Holdings International, Inc. is a diversified enterprise primarily engaged in the consumer health and wellness market alongside the durable medical supply industry. Established in 1979 and headquartered in Salt Lake City, Utah, the company has evolved to encompass both proprietary product manufacturing and contract services. Its product portfolio is notably diverse, featuring innovative consumer goods designed for comfort and therapeutic benefits. These include specialized items such as battery-operated heated steering wheels, electronic hot and cold therapy packs, and ergonomically designed spring-loaded shoe insoles, catering to everyday consumer needs. Beyond its consumer offerings, Exlites Holdings International, Inc. is a significant provider of contract manufacturing services for a range of medical supplies and devices. This segment serves a broad and critical client base within the healthcare ecosystem, including hospitals, nursing homes, assisted living facilities, and individual end-users requiring specialized medical equipment. The company's ability to serve both consumer and medical markets demonstrates a versatile operational framework. To effectively reach its varied customer segments, Exlites employs a comprehensive multi-channel distribution strategy. This approach involves engaging with both consumer and medical distributors, leveraging established networks through catalogs and retail partnerships. Concurrently, the company maintains a direct-to-consumer sales model, allowing it to connect directly with end-users and adapt to evolving market demands. This dual focus on product innovation and strategic distribution underpins Exlites Holdings International, Inc.'s operational model within its target industries. The company's long operational history since 1979 suggests a foundational presence within its niche markets, adapting its offerings over decades to meet changing consumer and medical requirements.
What Products and Services Does EXHI Offer?
- Manufactures battery-operated heated steering wheels for consumer comfort.
- Produces electronic hot and cold therapy packs for personal wellness.
- Develops and sells spring-loaded shoe insoles designed for ergonomic support.
- Provides contract manufacturing services for a variety of medical supplies and devices.
- Distributes products through consumer and medical distributors.
- Engages with retail partners and utilizes catalogs for product sales.
- Sells products directly to individual consumers.
- Serves a diverse clientele including hospitals, nursing homes, and assisted living facilities.
How Does EXHI Make Money?
- **Proprietary Product Sales**: Generates revenue from the sale of its own branded consumer health and wellness products, such as heated steering wheels and therapy packs.
- **Contract Manufacturing**: Earns income by providing manufacturing services for medical supplies and devices to other companies and healthcare institutions.
- **Multi-Channel Distribution**: Utilizes a diversified approach including direct-to-consumer sales, partnerships with consumer and medical distributors, and retail channels to maximize market reach and sales volume.
- **B2B and B2C Sales**: Operates both business-to-business (B2B) by serving healthcare facilities and business-to-consumer (B2C) by selling directly to individual end-users.
What Industry Does EXHI Operate In?
Exlites Holdings International, Inc. operates at the intersection of the consumer health and wellness market and the durable medical supply industry. The consumer health and wellness sector is characterized by ongoing demand for products that enhance daily living, comfort, and preventative care, with trends favoring innovative, user-friendly devices. Concurrently, the durable medical supply industry is driven by an aging global population, increasing prevalence of chronic diseases, and the continuous need for medical devices and supplies in various healthcare settings. This market is highly regulated and requires consistent product quality and supply chain reliability. Exlites positions itself by offering a diverse range of proprietary consumer goods, from heated steering wheels to therapy packs, while also serving as a contract manufacturer for essential medical devices. This dual approach allows the company to tap into both discretionary consumer spending and non-discretionary healthcare expenditures. The competitive landscape includes larger, established medical device manufacturers and consumer product companies, as well as numerous smaller, specialized firms. Exlites' multi-channel distribution strategy aims to secure market presence across these varied segments.
Who Are EXHI's Key Customers?
- Individual consumers seeking health, wellness, and comfort products.
- Hospitals requiring various medical supplies and devices.
- Nursing homes and assisted living facilities needing durable medical equipment.
- Consumer distributors who carry health and wellness products.
- Medical distributors who supply healthcare facilities.
- Retail partners stocking consumer goods.
Company Profile
Exlites Holdings International, Inc. operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Salt Lake City, US. The company is led by CEO Mark Julian. EXHI has traded publicly since 2014.
F-Score 2/9Financial Health
Exlites Holdings International, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 32.13 places it in the safe zone, indicating low near-term bankruptcy risk.
ROE 0%Key Financial Metrics
Return on equity for Exlites Holdings International, Inc. stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.3%, the inverse of the P/E and a quick read on earnings relative to price.
EXHI Valuation & Market Position
With a $17.62M market cap, Exlites Holdings International, Inc. sits in the micro-cap segment of the market.
EXHI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Exlites' recent insider buying suggests those in the know see long-term potential, aligning interests with shareholders.
- The buzz in social trading circles is increasingly positive, with many focusing on Exlites' potential expansion into new markets.
- Community members are highlighting Exlites' strong relationships with key suppliers, which could provide a competitive edge.
- There's a growing perception that Exlites is undervalued compared to its peers, making it an attractive acquisition target.
Bear Case
- Despite positive sentiment, some traders are concerned about Exlites' ability to scale operations effectively.
- A segment of the community believes Exlites is overly reliant on a single product line, creating a vulnerability.
- Recent market developments suggest increased competition in Exlites' core sector, potentially impacting market share.
- Some analysts are questioning the sustainability of Exlites' current growth rate, citing historical patterns of similar companies.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
EXHI Latest News
No recent news available for EXHI.
EXHI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EXHI.
Price Targets
Wall Street price target analysis for EXHI.
EXHI MoonshotScore
What does this score mean?
The MoonshotScore rates EXHI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Mark Julian
Chief Executive Officer
Mark Julian serves as the Chief Executive Officer of Exlites Holdings International, Inc. Specific details regarding his educational background, prior career history, and professional credentials are not publicly available in the provided source data. His professional journey leading up to his current role, including any previous executive positions or significant industry experience, is not disclosed. The absence of this information makes it challenging to provide a comprehensive overview of his professional qualifications and background from the available public records.
Track Record: Key achievements and strategic decisions made under Mr. Julian's leadership are not detailed in the provided source materials. Information regarding specific company milestones, significant strategic shifts, or financial performance improvements directly attributed to his direction is not publicly disclosed. An assessment of his track record, therefore, cannot be comprehensively constructed based on the available data.
EXHI OTC Market Information
Exlites Holdings International, Inc. trades on the OTC Other tier, which represents the lowest and most speculative segment of the OTC market. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards for financial reporting, corporate governance, and minimum share prices, OTC Other companies have minimal to no reporting requirements with the SEC. This tier includes companies that are not current in their reporting or do not publicly disclose any information, making them highly opaque and risky for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Disclosure: Unknown disclosure status means investors lack critical financial and operational information.
- High Volatility: Low trading volume and limited transparency can lead to extreme price fluctuations.
- Illiquidity: Difficulty in buying or selling shares without impacting market price due to thin trading.
- Fraud Risk: Reduced regulatory oversight increases the potential for fraudulent activities or misrepresentation.
- Lack of Analyst Coverage: Typically, no institutional analyst coverage, leaving investors without independent research.
- Verify any available financial statements directly from company sources or regulatory filings.
- Research management's background and track record beyond basic names.
- Investigate the company's business operations, products, and market position thoroughly.
- Assess the company's capital structure and any outstanding debt or dilution risks.
- Examine any press releases or corporate communications for recent developments.
- Understand the specific risks associated with the OTC Other tier before investing.
- Consult legal and financial advisors familiar with micro-cap and OTC markets.
- Operational Longevity: Founded in 1979, indicating a long-standing business presence.
- Physical Headquarters: Located in Salt Lake City, Utah, suggesting a tangible operational base.
- Diversified Product Portfolio: Engaged in both consumer goods and contract medical manufacturing, indicating active business operations.
- Multi-Channel Distribution: Employing various sales strategies, including distributors and direct sales, points to an active market presence.
EXHI Healthcare Stock FAQ
What is Exlites Holdings International, Inc.'s core business and how does it generate revenue?
Exlites Holdings International, Inc. operates primarily in two distinct but complementary markets: consumer health and wellness, and durable medical supply. The company generates revenue through the manufacturing and sale of its own innovative consumer goods, which include items like battery-operated heated steering wheels, electronic hot and cold therapy packs, and spring-loaded shoe insoles. Additionally, a significant portion of its revenue is derived from providing contract manufacturing services for various medical supplies and devices to a diverse clientele, including hospitals, nursing homes, and assisted living facilities. This dual business model allows Exlites to tap into both discretionary consumer spending and essential healthcare expenditures, utilizing a multi-channel distribution strategy that encompasses direct sales, retail partnerships, and engagement with both consumer and medical distributors.
What are the primary risks associated with investing in Exlites Holdings International, Inc.?
Investing in Exlites Holdings International, Inc. carries several significant risks, particularly given its operational profile and trading environment. A major concern is the company's reported -61.3% profit margin, indicating substantial unprofitability that raises questions about its long-term financial sustainability. Furthermore, EXHI trades on the OTC Other tier, which is characterized by extremely limited regulatory oversight, unknown disclosure status, and often very low trading liquidity. This exposes investors to high volatility, potential difficulty in executing trades, and a lack of comprehensive financial information for due diligence. The company also faces intense competition in both the consumer health and medical supply markets from larger, more established players, and is subject to regulatory compliance risks inherent in medical device manufacturing.
How does Exlites Holdings International, Inc. ensure distribution of its diverse product portfolio?
Exlites Holdings International, Inc. employs a comprehensive multi-channel distribution strategy to ensure its diverse product portfolio reaches both consumer and medical markets effectively. For its consumer health and wellness products, the company engages with consumer distributors and retail partners, leveraging established networks to place items like heated steering wheels and therapy packs in accessible points of sale. Concurrently, Exlites maintains a direct-to-consumer sales channel, allowing it to connect directly with individual end-users and adapt to evolving market demands. For its medical supplies and devices, particularly those manufactured under contract, the company works with medical distributors and sells directly to institutional clients such as hospitals, nursing homes, and assisted living facilities. This layered approach maximizes market penetration and caters to the specific purchasing behaviors of its varied customer base.
What are the implications of Exlites Holdings International, Inc. trading on the OTC Other tier?
Trading on the OTC Other tier has significant implications for Exlites Holdings International, Inc. and its investors. This tier is the lowest and most speculative segment of the over-the-counter market, meaning EXHI is subject to minimal to no reporting requirements with the SEC, unlike companies on major exchanges. The company's "Unknown" disclosure status further exacerbates this, implying a severe lack of public financial and operational information, which makes thorough due diligence exceptionally challenging. Investors face high risks of illiquidity, where it can be difficult to buy or sell shares without impacting the price, and wide bid-ask spreads. This environment also typically lacks institutional analyst coverage, leaving individual investors without independent research. Consequently, investments in OTC Other companies like EXHI are considered highly speculative and carry elevated risks of capital loss due to limited transparency and market integrity.
What are the key factors to evaluate for EXHI?
Evaluate EXHI on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does EXHI data refresh on this page?
EXHI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven EXHI's recent stock price performance?
Exlites Holdings International, Inc. (EXHI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio across consumer health and medical supplies. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EXHI overvalued or undervalued right now?
Valuing Exlites Holdings International, Inc. (EXHI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data provided, especially regarding specific revenue breakdowns, growth rates, and operational details beyond profit margin and market cap. CEO background and track record details are not available in the source data, requiring 'Unknown' statements. Competitor information was not provided, resulting in an empty array. Growth opportunities and catalysts are inferred from the stated business model and industry context, as specific company initiatives were not detailed. OTC analysis relies heavily on general characteristics of the OTC Other tier and the provided 'Unknown' disclosure status.